The controversy over the pricing of Mylan's EpiPen continued to rage Thursday, even after the generic pharmaceutical company with extensive operations in Pittsburgh announced steps earlier in the day to make the allergy medicine more affordable to those paying out of pocket.
Mylan has been facing intense media and political criticism over the price increases of EpiPen packs, a treatment to treat severe allergic reactions that have gone from costing under $100 in 2007 to more than $600 today. Mylan…
The controversy over the pricing of Mylan's EpiPen continued to rage Thursday, even after the generic pharmaceutical company with extensive operations in Pittsburgh announced steps earlier in the day to make the allergy medicine more affordable to those paying out of pocket.
Mylan has been facing intense media and political criticism over the price increases of EpiPen packs, a treatment to treat severe allergic reactions that have gone from costing under $100 in 2007 to more than $600 today. Mylan…